|
1
|
Li Z, Huang Z and Bai L: The P2X7 receptor
in osteoarthritis. Front Cell Dev Biol. 9(628330)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yu D, Jordan KP, Bedson J, Englund M,
Blyth F, Turkiewicz A, Prieto-Alhambra D and Peat G: Population
trends in the incidence and initial management of osteoarthritis:
Age-period-cohort analysis of the clinical practice research
datalink, 1992-2013. Rheumatology (Oxford). 56:1902–1917.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fu C, Zheng C, Lin J, Ye J, Mei Y, Pan C,
Wu G, Li X, Ye H and Liu X: Cibotium barometz polysaccharides
stimulate chondrocyte proliferation in vitro by promoting G1/S cell
cycle transition. Mol Med Rep. 15:3027–3034. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fischer H, Koenig U, Eckhart L and
Tschachler E: Human caspase 12 has acquired deleterious mutations.
Biochem Biophys Res Commun. 293:722–726. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Charlier E, Relic B, Deroyer C, Malaise O,
Neuville S, Collée J, Malaise MG and De Seny D: Insights on
molecular mechanisms of chondrocytes death in osteoarthritis. Int J
Mol Sci. 17(2146)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liao L, Zhang S, Gu J, Takarada T, Yoneda
Y, Huang J, Zhao L, Oh CD, Li J, Wang B, et al: Deletion of Runx2
in articular chondrocytes decelerates the progression of
DMM-induced osteoarthritis in adult mice. Sci Rep.
7(2371)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen D, Shen J, Zhao W, Wang T, Han L,
Hamilton JL and Im HJ: Osteoarthritis: Toward a comprehensive
understanding of pathological mechanism. Bone Res.
5(16044)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang K, Li Y, Han R, Cai G, He C, Wang G
and Jia D: T140 blocks the SDF-1/CXCR4 signaling pathway and
prevents cartilage degeneration in an osteoarthritis disease model.
PLoS One. 12(e176048)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Samways DS, Li Z and Egan TM: Principles
and properties of ion flow in P2X receptors. Front Cell Neurosci.
8(6)2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shao BZ, Xu ZQ, Han BZ, Su DF and Liu C:
NLRP3 inflammasome and its inhibitors: A review. Front Pharmacol.
6(262)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Swanson KV, Deng M and Ting JPY: The NLRP3
inflammasome: Molecular activation and regulation to therapeutics.
Nat Rev Immunol. 19:477–489. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xing Y, Yao X, Li H, Xue G, Guo Q, Yang G,
An L, Zhang Y and Meng G: Cutting edge: TRAF6 mediates TLR/IL-1R
signaling-induced nontranscriptional priming of the NLRP3
inflammasome. J Immunol. 199:1561–1566. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Scanzello CR and Goldring SR: The role of
synovitis in osteoarthritis pathogenesis. Bone. 51:249–257.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang S, Mobasheri A, Zhang Y, Wang Y, Dai
T and Zhang Z: Exogenous stromal cell-derived factor-1 (SDF-1)
suppresses the NLRP3 inflammasome and inhibits pyroptosis in
synoviocytes from osteoarthritic joints via activation of the AMPK
signaling pathway. Inflammopharmacology. 29:695–704.
2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
McAllister MJ, Chemaly M, Eakin AJ, Gibson
DS and McGilligan VE: NLRP3 as a potentially novel biomarker for
the management of osteoarthritis. Osteoarthr Cartilage. 26:612–619.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Di Virgilio F: The therapeutic potential
of modifying inflammasomes and NOD-like receptors. Pharmacol Rev.
65:872–905. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pernicova I and Korbonits M:
Metformin-mode of action and clinical implications for diabetes and
cancer. Nat Rev Endocrinol. 10:143–156. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gao Y, Li Y, Xue J, Jia Y and Hu J: Effect
of the anti-diabetic drug metformin on bone mass in ovariectomized
rats. Eur J Pharmacol. 635:231–236. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Park MJ, Moon SJ, Baek JA, Lee EJ, Jung
KA, Kim EK, Kim DS, Lee JH, Kwok SK, Min JK, et al: Metformin
augments anti-inflammatory and chondroprotective properties of
mesenchymal stem cells in experimental osteoarthritis. J Immunol.
203:127–136. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nie L, Zhao P, Yue Z, Zhang P, Ji N, Chen
Q and Wang Q: Diabetes induces macrophage dysfunction through
cytoplasmic dsDNA/AIM2 associated pyroptosis. J Leukoc Biol.
110:497–510. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang J, Huang L, Shi X, Yang L, Hua F, Ma
J, Zhu W, Liu X, Xuan R, Shen Y, et al: Metformin protects against
myocardial ischemia-reperfusion injury and cell pyroptosis via
AMPK/NLRP3 inflammasome pathway. Aging (Albany NY). 12:24270–24287.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tan Y, Chen J, Jiang Y, Chen X, Li J, Chen
B and Gao J: The anti-periodontitis action of metformin via
targeting NLRP3 inflammasome. Arch Oral Biol.
114(104692)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Feng X, Pan J, Li J, Zeng C, Qi W, Shao Y,
Liu X, Liu L, Xiao G, Zhang H, et al: Metformin attenuates
cartilage degeneration in an experimental osteoarthritis model by
regulating AMPK/mTOR. Aging (Albany NY). 12:1087–1103.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Glasson SS, Chambers MG, Van Den Berg WB
and Little CB: The OARSI histopathology initiative-recommendations
for histological assessments of osteoarthritis in the mouse.
Osteoarthr Cartilage. 18 (Suppl 3):S17–S23. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kirschneck C, Batschkus S, Proff P,
Köstler J, Spanier G and Schröder A: Valid gene expression
normalization by RT-qPCR in studies on hPDL fibroblasts with focus
on orthodontic tooth movement and periodontitis. Sci Rep.
7(14751)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hildebrand T, Laib A, Müller R, Dequeker J
and Rüegsegger P: Direct three-dimensional morphometric analysis of
human cancellous bone: Microstructural data from spine, femur,
iliac crest, and calcaneus. J Bone Miner Res. 14:1167–1174.
1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Spel L and Martinon F: Inflammasomes
contributing to inflammation in arthritis. Immunol Rev. 294:48–62.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Toldo S, Mezzaroma E, Buckley LF, Potere
N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW and Abbate A:
Targeting the NLRP3 inflammasome in cardiovascular diseases.
Pharmacol Ther. 236(108053)2021.PubMed/NCBI View Article : Google Scholar : (Online ahead of
print).
|
|
30
|
Denoble AE, Huffman KM, Stabler TV, Kelly
SJ, Hershfield MS, McDaniel GE, Coleman RE and Kraus VB: Uric acid
is a danger signal of increasing risk for osteoarthritis through
inflammasome activation. Proc Natl Acad Sci USA. 108:2088–2093.
2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang Y, Zheng Y and Li H: NLRP3
inflammasome plays an important role in the pathogenesis of
collagen-induced arthritis. Mediat Inflamm.
2016(9656270)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhang L, Li X, Zhang H, Huang Z, Zhang N,
Zhang L, Xing R and Wang P: Agnuside alleviates synovitis and
fibrosis in knee osteoarthritis through the inhibition of HIF-1α
and NLRP3 inflammasome. Mediat Inflamm.
2021(5534614)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wojdasiewicz P, Poniatowski ŁA and
Szukiewicz D: The role of inflammatory and anti-inflammatory
cytokines in the pathogenesis of osteoarthritis. Mediat Inflamm.
2014(561459)2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li J, Zhang B, Liu WX, Lu K, Pan H, Wang
T, Oh CD, Yi D, Huang J, Zhao L, et al: Metformin limits
osteoarthritis development and progression through activation of
AMPK signalling. Ann Rheum Dis. 79:635–645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang M, Liu Y, Huan Z, Wang Y and Xu J:
Metformin protects chondrocytes against IL-1β induced injury by
regulation of the AMPK/NF-κB signaling pathway. Pharmazie.
75:632–636. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Xian H, Liu Y, Rundberg Nilsson A,
Gatchalian R, Crother TR, Tourtellotte WG, Zhang Y, Aleman-Muench
GR, Lewis G, Chen W, et al: Metformin inhibition of mitochondrial
ATP and DNA synthesis abrogates NLRP3 inflammasome activation and
pulmonary inflammation. Immunity. 54:1463–1477.e11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Du RW and Bu WG: Metformin improves
depressive-like symptoms in mice via inhibition of peripheral and
central NF-κB-NLRP3 inflammation activation. Exp Brain Res.
238:2549–2556. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Muraoka T, Hagino H, Okano T, Enokida M
and Teshima R: Role of subchondral bone in osteoarthritis
development: A comparative study of two strains of guinea pigs with
and without spontaneously occurring osteoarthritis. Arthritis
Rheum. 56:3366–3374. 2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hayami T, Pickarski M, Zhuo Y, Wesolowski
GA, Rodan GA and Duong LT: Characterization of articular cartilage
and subchondral bone changes in the rat anterior cruciate ligament
transection and meniscectomized models of osteoarthritis. Bone.
38:234–243. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fang H, Huang L, Welch I, Norley C,
Holdsworth DW, Beier F and Cai D: Early changes of articular
cartilage and subchondral bone in the DMM mouse model of
osteoarthritis. Sci Rep. 8(2855)2018.PubMed/NCBI View Article : Google Scholar
|
